Intervention to Reduce Unwanted Loneliness in Family Caregivers of People With Alzheimer (NCT07639645) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Intervention to Reduce Unwanted Loneliness in Family Caregivers of People With Alzheimer
Spain50 participantsStarted 2026-10
Plain-language summary
The absence of social relationships negatively affects physical, psychological, and social health. In other words, it alters people's quality of life and makes active aging difficult. The investigators have designed a study to reduce unwanted loneliness and improve the living with process of family caregivers of people with Alzheimer disease through multiple interventions (music therapy, health education)
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Family caregivers of people with Alzheimer's disease (AD).
* Primary family caregivers who live with the person with AD.
* The person with AD must be enrolled in one of the adult day care centers where the study is conducted.
* Ability to communicate in Spanish and/or Valencian.
Exclusion Criteria:
* Presence of moderate or severe cognitive impairment, mental disorder, significant sensory impairment, disabling chronic illness, or any medical condition that contraindicates participation in any of the study activities.
* Family caregivers of institutionalized individuals.
* Family caregivers of people with AD who have died.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is specifically for family caregivers of people with Alzheimer's — not the patients themselves — so how do I find out whether I qualify as a caregiver and whether this study might be relevant to my situation?
2The trial is listed as 'not yet recruiting,' so how long might it be before it actually starts enrolling, and is there anything I should be doing in the meantime to address caregiver loneliness?
3This study measures loneliness using something called the Jong Gierveld Loneliness Scale — can you explain what that measures and whether my own level of loneliness or social isolation would be something worth formally assessing right now, even outside a trial?
4Since this trial has no assigned phase and focuses on a psychological and social outcome rather than a medication, what do we know about the safety or effectiveness of whatever intervention they're planning to test, and are there already proven supports for caregiver loneliness I could access today?
5The trial also looks at 'living with chronic conditions from the family perspective' — does that mean it's designed for caregivers who are managing their own health challenges on top of caring for someone with Alzheimer's, and how would that affect whether this might be a good fit for me?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Score on the Jong Gierveld Lonelinss Scale
Timeframe: From the beginning of the enrollement until the end of the intervention at 12 weeks
2
Living with chronic conditions from the family perspective
Timeframe: From the enrollment to the end of the intervention at 12 weeks